Sensei Biotherapeutics (SNSE) has the highest short interest by a US stock in the Biotechnology Industry, with 84.43% of float sold short (863,539 shares).
| ASSET | SHARES SHORT | FLOAT | SHORT % OF FLOAT | SHORT RATIO |
|---|---|---|---|---|
Sensei Biotherapeutics (SNSE) | 863,539 | 810,857 | 84.43% | .89 |
Monopar Therapeutics (MNPR) | 1.6841M | 4.3968M | 65.83% | 9.56 |
LENZ Therapeutics (LENZ) | 9.0334M | 18.4821M | 52.74% | 13.33 |
Kalvista Pharmaceuticals (KALV) | 20.3595M | 29.5563M | 42.91% | 23.09 |
Keros Therapeutics (KROS) | 1.4948M | 19.1735M | 39.58% | 4.47 |
ARS Pharmaceuticals (SPRY) | 25.3412M | 41.0356M | 38.8% | 21.17 |
Acurx Pharmaceuticals LLC (ACXP) | 102,286 | 2.7264M | 38.46% | .14 |
Sana Biotechnology (SANA) | 39.379M | 177.2823M | 38.21% | 16.79 |
Tango Therapeutics (TNGX) | 40.3702M | 67.7443M | 38.05% | 12.21 |
Intellia Therapeutics (NTLA) | 38.9459M | 111.9386M | 37.37% | 9.89 |
Immunitybio (IBRX) | 135.542M | 382.3443M | 35.88% | 3.34 |
Replimune (REPL) | 16.3352M | 62.8947M | 35.23% | 10.95 |
Recursion Pharmaceuticals (RXRX) | 173.9268M | 510.3103M | 34.89% | 9.8 |
Arcturus Therapeutics (ARCT) | 6.4505M | 26.2836M | 31.53% | 12.73 |
iSpecimen (ISPC) | 580,752 | 29.6619M | 31.46% | .18 |
Neurogene (NGNE) | 4.0292M | 5.1021M | 31.17% | 18.95 |
AnaptysBio (ANAB) | 4.8115M | 17.263M | 30.63% | 9.76 |
Iovance Biotherapeutics (IOVA) | 110.8322M | 353.4095M | 30.05% | 5.24 |
Novavax (NVAX) | 44.9904M | 140.252M | 29.95% | 10.07 |
Absci (ABSI) | 37.3289M | 135.0274M | 29.08% | 13.62 |
Abeona Therapeutics (ABEO) | 15.8444M | 42.5152M | 28.13% | 15.17 |
Organogenesis (ORGO) | 12.7906M | 57.977M | 27.73% | 16.55 |
Immunocore (IMCR) | 10.1448M | 45.0557M | 27.49% | 26.37 |
Twist Bioscience (TWST) | 14.1497M | 54.6452M | 27.04% | 11.16 |
Stoke Therapeutics (STOK) | 12.8188M | 43.8313M | 26.94% | 16.93 |
Historical short interest data is not available.
